IBB Biotech is due for a run

At some point there will be a boom biotechnology stocks. They haven't done much in the past ten years. I believe IBB will pass 250 within the decade. However, if the market remains stable, without any 20%+ corrections, I think IBB hits 250 to 300 in the next year
Beyond Technical AnalysisbiotechbiotechnologybiotechstocksFundamental AnalysisIBBTrend Analysis

También en:

Exención de responsabilidad